Hitachi collaborates with CLB to fight cancer using AI

Tokyo headquartered Hitachi, Ltd. and Centre Leon Berard (CLB), a leading French Comprehensive Cancer Center in Lyon-Fra...

November 7, 2019 | Thursday | News
Olympus unveils corporate strategy

Olympus Corporation has announced its Corporate Strategy in central Tokyo. The announcement follows the company's e...

November 7, 2019 | Thursday | News
Takeda divests select products to STADA for $660M

Japan based Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a portfo...

November 6, 2019 | Wednesday | News
Fujifilm’s rapid TB diagnostic kit receives recognition

FUJIFILM Corporation is pleased to announce that its “Rapid Tuberculosis Diagnostic Kit” has won the Good De...

November 5, 2019 | Tuesday | News
Synthetic compound provides fast screening for potential drugs

A simple assay may benefit drug discovery for treating diabetes, Parkinson's, and Alzheimers disease, as well as studies...

November 4, 2019 | Monday | News
Promethera Biosciences spreads business activity to Japan

Promethera Biosciences SA (Group), a global innovator in cell-based medicines and liver diseases, had announced the foun...

November 4, 2019 | Monday | News
EMA and FDA accept marketing applications for Chugai's Satralizumab

Chugai Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Ap...

October 31, 2019 | Thursday | News
Pandion, Astellas collaborate for pancreas targeted immunomodulators

US headquartered Pandion Therapeutics, Inc., and Japan based Astellas Pharma Inc. have announced the signing of a Licens...

October 31, 2019 | Thursday | News
Lobsor Pharma receives Japanese patent for APD solution

Lobsor Pharmaceuticals AB, a privately held Swedish company based in Uppsala, has announced the Japanese Patent Office h...

November 1, 2019 | Friday | News
Hitachi takes advanced Proton Therapy to the US

Japan headquartered Hitachi, Ltd., has announced that it has provided its advanced proton therapy system to Sibley Memor...

October 31, 2019 | Thursday | News
Biogen plans regulatory filing for Aducanumab for Alzheimer's

Biogen and Eisai, Co., Ltd. (Tokyo, Japan) has announced that, after consulting with the U.S. Food and Drug Administrati...

October 23, 2019 | Wednesday | News
MIMS and Ashfield Communications combine operations in Japan

MIMS Group, Asia's largest multi-channel provider of drug information, medical communications, events management and mar...

October 24, 2019 | Thursday | News
Rentschler Biopharma to expand Japanese operation base

Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biop...

October 23, 2019 | Wednesday | News
Takeda acquires license for celiac disease therapy

Japanese firm Takeda Pharmaceutical Company  and US based COUR Pharmaceutical Development Company, Inc. have announ...

October 22, 2019 | Tuesday | News
Trastuzumab deruxtecan gets FDA priority review to treat metastatic breast cancer

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) have announced that the US Food and Drug Administration...

October 18, 2019 | Friday | News
Avidity Science acquires Edstrom Japan Ltd

Avidity Science is pleased to announce it has completed its acquisition of Edstrom Japan Ltd. The acquisition furthers A...

October 17, 2019 | Thursday | News
Dr. Steven Rosenberg's achievements in cancer immunotherapy motivate young researchers

Using the function of the individual's own immune system to combat cancer, this out-of-the-box concept was proposed by D...

October 17, 2019 | Thursday | News
Astellas transfers three products in Asia region to Daiichi Sankyo

Astellas Pharma Inc. has announced that subsidiaries of Astellas will transfer their marketing authorizations, trademark...

October 17, 2019 | Thursday | News